BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27159390)

  • 1. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.
    Gebremariam T; Lin L; Liu M; Kontoyiannis DP; French S; Edwards JE; Filler SG; Ibrahim AS
    J Clin Invest; 2016 Jun; 126(6):2280-94. PubMed ID: 27159390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CotH3 mediates fungal invasion of host cells during mucormycosis.
    Gebremariam T; Liu M; Luo G; Bruno V; Phan QT; Waring AJ; Edwards JE; Filler SG; Yeaman MR; Ibrahim AS
    J Clin Invest; 2014 Jan; 124(1):237-50. PubMed ID: 24355926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
    Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.
    Gebremariam T; Alkhazraji S; Soliman SSM; Gu Y; Jeon HH; Zhang L; French SW; Stevens DA; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
    Sci Adv; 2019 Jun; 5(6):eaaw1327. PubMed ID: 31206021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.
    Liu M; Spellberg B; Phan QT; Fu Y; Fu Y; Lee AS; Edwards JE; Filler SG; Ibrahim AS
    J Clin Invest; 2010 Jun; 120(6):1914-24. PubMed ID: 20484814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of mucormycosis.
    Ibrahim AS; Spellberg B; Walsh TJ; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1(Suppl 1):S16-22. PubMed ID: 22247441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis.
    Ibrahim AS; Gebremariam T; Lin L; Luo G; Husseiny MI; Skory CD; Fu Y; French SW; Edwards JE; Spellberg B
    Mol Microbiol; 2010 Aug; 77(3):587-604. PubMed ID: 20545847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin.
    Abe F; Shibuya H; Tateyama M; Ommura Y; Azumi N; Kimura K
    Acta Pathol Jpn; 1986 Oct; 36(10):1507-12. PubMed ID: 3099540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability.
    Artis WM; Fountain JA; Delcher HK; Jones HE
    Diabetes; 1982 Dec; 31(12):1109-14. PubMed ID: 6816646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.
    Bellanger AP; Tatara AM; Shirazi F; Gebremariam T; Albert ND; Lewis RE; Ibrahim AS; Kontoyiannis DP
    J Infect Dis; 2016 Jul; 214(1):114-21. PubMed ID: 26984141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.
    Ibrahim AS
    Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferiprone iron chelation as a novel therapy for experimental mucormycosis.
    Ibrahim AS; Edwards JE; Fu Y; Spellberg B
    J Antimicrob Chemother; 2006 Nov; 58(5):1070-3. PubMed ID: 16928702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection.
    Lewis RE; Liao G; Wang W; Prince RA; Kontoyiannis DP
    Virulence; 2011; 2(4):348-55. PubMed ID: 21788730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-killed yeast protects diabetic ketoacidotic-steroid treated mice from pulmonary mucormycosis.
    Luo G; Gebremariam T; Clemons KV; Stevens DA; Ibrahim AS
    Vaccine; 2014 Jun; 32(29):3573-6. PubMed ID: 24814556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of iron and desferrioxamine on Rhizopus infection.
    Abe F; Inaba H; Katoh T; Hotchi M
    Mycopathologia; 1990 May; 110(2):87-91. PubMed ID: 2142253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of EGFR Signaling Protects from Mucormycosis.
    Watkins TN; Gebremariam T; Swidergall M; Shetty AC; Graf KT; Alqarihi A; Alkhazraji S; Alsaadi AI; Edwards VL; Filler SG; Ibrahim AS; Bruno VM
    mBio; 2018 Aug; 9(4):. PubMed ID: 30108171
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Szebenyi C; Gu Y; Gebremariam T; Kocsubé S; Kiss-Vetráb S; Jáger O; Patai R; Spisák K; Sinka R; Binder U; Homa M; Vágvölgyi C; Ibrahim AS; Nagy G; Papp T
    mBio; 2023 Feb; 14(1):e0338622. PubMed ID: 36625576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine.
    Liu M; Lin L; Gebremariam T; Luo G; Skory CD; French SW; Chou TF; Edwards JE; Ibrahim AS
    PLoS Pathog; 2015 May; 11(5):e1004842. PubMed ID: 25974051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.
    Ibrahim AS; Bowman JC; Avanessian V; Brown K; Spellberg B; Edwards JE; Douglas CM
    Antimicrob Agents Chemother; 2005 Feb; 49(2):721-7. PubMed ID: 15673756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential anti-mucor agents by targeting endothelial cell receptor glucose-regulated protein-78 using
    Singh A; Varadarajan A; Pant P; Singh TP; Vikram NK; Sharma S; Sharma P
    J Biomol Struct Dyn; 2024 May; 42(8):4344-4355. PubMed ID: 37288794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.